Grove Biopharma

Chicago, IL · Founded 2020 · Privately Held (backing)

Operator of a modality biotechnology company intended to treat unmet medical needs in oncology, chronic inflammatory, and neurodegenerative diseases. Grove Biopharma is based in Chicago, IL and was founded in 2020. Its last reported valuation was $64 million in Apr 2025. It has raised $44 million.

Last reported valuation
$64.0M
Oct 2026
Priced at
—
Total raised
$44.0M
Last round
—

Who backs Grove Biopharma?

13 investors
InvestorType
DCVC BioVenture capital
Skydeck CapitalFamily office
Mansueto OfficeFamily office
Deepwork Capital—
Eli Lilly—
Gradiant—
InVivium Capital—
Joseph Mansueto—
Mansueto Investments—
Northwestern University—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Grove Biopharma investors

13 investors are on record for Grove Biopharma, including DCVC Bio, Skydeck Capital, Mansueto Office and Deepwork Capital.

Free account
More of Grove Biopharma with a free account
  • ·The complete investor list: 13 names
  • ·Watch Grove Biopharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like Grove Biopharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View